Active

CELYNTRA THERAPEUTICS

Switched

BE0737829015

Rechtspersoon Public limited company 1 establishment

Rue Edouard Belin 2, 1435 Mont-Saint-Guibert Groothandel in farmaceutische en medische artikelen

Active for

6 year, 9 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 560,992

▲ 115% vs 2024

Profit

Caution

€ -3.1 million

▲ 52% vs 2024

Debts

High

€ 17.6 million

▲ 19% vs 2024

CELYNTRA THERAPEUTICS from Mont-Saint-Guibert, company number BE0737829015, closed financial year 2025 with a result of € -3.1 million after tax. For that financial year CELYNTRA THERAPEUTICS recorded a gross margin of € 560,992 and equity of € -9.6 million. Compared with financial year 2024, the result moved from € -6.4 million to € -3.1 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.

What happened at CELYNTRA THERAPEUTICS?

What happened at CELYNTRA THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Jason Conner stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 3.1 million. Source: NBB ↗
  • Jason Conner became a director. NBB
  • New establishment in Mont-Saint-Guibert. KBO
  • Start of the company according to the CBE. KBO

In short

From € 328,858 loss in 2021 to € 3.1 million loss in 2025.

On average € 44,200 of value added per employee in 2025.

A new publication or filing at CELYNTRA THERAPEUTICS? We notify you, reason included.

Follow CELYNTRA THERAPEUTICS

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Jason Conner

Managing director

Also active at: Ncardia Holding, Cellistic

since 2026 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Edouard Belin 2

1435 Mont-Saint-Guibert

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0737.829.015
VAT number
BE 0737.829.015
Registered office
Rue Edouard Belin 2, 1435 Mont-Saint-Guibert
Names & denominations
CELYNTRA THERAPEUTICS
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
19 November 2019
Peppol
Active · Active since 27 Nov 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What is the enterprise number of CELYNTRA THERAPEUTICS?
The enterprise number of CELYNTRA THERAPEUTICS is BE0737829015.
What is the address of CELYNTRA THERAPEUTICS?
The registered office of CELYNTRA THERAPEUTICS is located at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert.
When was CELYNTRA THERAPEUTICS founded?
CELYNTRA THERAPEUTICS was founded on 19 November 2019.
What is the main activity of CELYNTRA THERAPEUTICS?
The main activity of CELYNTRA THERAPEUTICS is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does CELYNTRA THERAPEUTICS have a website?
No website is currently known for CELYNTRA THERAPEUTICS.
How much profit did CELYNTRA THERAPEUTICS make in 2025?
CELYNTRA THERAPEUTICS recorded a loss after taxes of € 3,065,141 in financial year 2025.
What is the revenue of CELYNTRA THERAPEUTICS?
As a small company, CELYNTRA THERAPEUTICS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 560,992.
How many employees does CELYNTRA THERAPEUTICS have?
According to the 2025 annual accounts, CELYNTRA THERAPEUTICS has 12.7 full-time equivalents (FTE).
Where can I find the annual accounts of CELYNTRA THERAPEUTICS?
CELYNTRA THERAPEUTICS files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of CELYNTRA THERAPEUTICS?
According to the 2025 annual accounts, the directors of CELYNTRA THERAPEUTICS are: Jason Conner.